Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$206K Buy
1,933
+223
+13% +$27K 0.02% 320
2026
Q1
$280K Buy
1,710
+196
+13% +$30.1K 0.02% 241
2025
Q4
$263K Sell
1,514
-39
-3% -$7.12K 0.02% 257
2025
Q3
$224K Buy
+1,553
New +$190K 0.02% 290

Other funds holding INSM

American Trust's INSM Position: Q2 2026 in Review

American Trust increased its Insmed (INSM) stake by 13% in Q2 2026, buying an estimated $27K and bringing the position to 1,933 shares worth $206K. The position accounts for 0.02% of the portfolio, ranked #320.

American Trust first reported a position in INSM in Q3 2025 and has held it in 4 quarters since. The position peaked at $280K in Q1 2026. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • American Trust held 1,933 shares of Insmed worth $206K as of Q2 2026.
  • American Trust bought 223 Insmed shares in Q2 2026, an estimated $27K.
  • Insmed made up 0.02% of American Trust's portfolio in Q2 2026, its #320 holding.
  • American Trust first reported a position in Insmed in Q3 2025 and has held it in 4 quarters since.
  • American Trust's Insmed position peaked at $280K in Q1 2026.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on American Trust's 13F filing for Q2 2026, filed 14 Aug 2026.